Celanese Corporation

Celanese Corporation (CE) Market Cap

Celanese Corporation has a market capitalization of $5.60B.

Price: $51.03

-2.94 (-5.45%)

Market Cap: 5.60B

NYSE · time unavailable

CEO: Scott A. Richardson

Sector: Basic Materials

Industry: Chemicals

IPO Date: 2005-01-21

Website: https://www.celanese.com

Celanese Corporation (CE) - Company Information

Market Cap: 5.60B|Sector: Basic Materials

Company Profile

Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a sweetener for use in various beverages, confections, and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acid for use in foods, beverages, and personal care products. The Acetate Tow segment provides acetate tows and flakes for use in filter products applications. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.

Analyst Sentiment

83%
Strong Buy

From 16 Active Polls

1Y Forecast: $65.60

▲ +28.6% Potential Upside

Consensus Target Metrics

Low Bound

$50

Median

$64

High Bound

$86

Average

$66

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$65.60
▲ +28.55% Upside
Low Target
$50.00
-2% Risk
Median Target
$63.50
24% Mid
High Target
$86.00
69% Max
Consensus
Hold
11 / 37 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)5,5967,2154,6344,6126,0606,2127,57214,86614,395
Enterprise Value ($M)16,39218,01116,30516,37618,20118,40719,56227,39226,613
Price to Earnings Ratio (P/E)-5.1140.9960.97-0.857.61-73.95-0.9932.0423.22
Price/Earnings-to-Growth Ratio (PEG)6.791.27-92.2415.15
Price to Sales Ratio (P/S)0.593.092.101.912.392.603.195.615.43
Price to Book Ratio (P/B)1.381.781.141.171.151.201.462.042.01
Price to Free Cash Flow Ratio (P/FCF)5.9394.9327.5812.0419.12-95.5719.46-1651.7576.98
Enterprise Value to Sales (EV/Sales)7.717.406.777.197.708.2510.3410.04
Enterprise Value to EBITDA (EV/EBITDA)49.5245.3739.67-16.6836.0451.42-16.7848.8347.95
Debt to Equity Ratio32.623.093.193.342.522.532.501.831.87

CE Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$51.03
Intrinsic Value$68.04
Market Alignment
Undervalued by 33.3%relative to calculated intrinsic value
9.00%
Exp: -3%-3%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$1.39B
Perpetuity TV Value$26.22B
Discounted TV (PV)$11.08B
TV Weighting %55.7%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CELANESE CORP (CE) — Investment Overview

🧩 Business Model Overview

Celanese operates as a specialty chemicals and engineered materials producer with an integrated value chain built around acetyl chemistry and downstream polymer production. The business model follows a familiar specialty-chemicals structure: (1) manufacture core chemical intermediates, (2) convert them into proprietary performance materials, and (3) sell into demanding end markets where qualification, application know-how, and supply reliability matter.

Customer stickiness is reinforced through “design-in” dynamics: engineers specify material performance and processing characteristics for long development cycles, and suppliers compete on technical support, consistent quality, and documentation required for production ramp-up. For many applications, once a material is approved, switching costs become material—not just commercial.

💰 Revenue Streams & Monetisation Model

Revenue is primarily driven by engineered materials and specialty chemicals demand, with exposure to cyclical end markets such as automotive, industrial manufacturing, and consumer durables. Monetisation tends to improve when the company captures value through (a) premium performance specifications, (b) stable customer qualification for high-grade materials, and (c) differentiated formulations and applications engineering.

Margin drivers are typically dominated by the interplay of:

  • Cost advantages from integrated production (ability to manage conversion efficiency and chemical intermediate utilization).
  • Feedstock and energy cost spreads between input chemicals and the pricing of downstream materials.
  • Product mix skewing toward higher-spec engineering polymers and specialty formulations rather than commodity-like volume.

While volumes can fluctuate with industrial demand, pricing power is generally exercised through specification-level differentiation rather than pure pass-through of commodities.

🧠 Competitive Advantages & Market Positioning

Celanese’s moat is best described as a combination of switching costs (customer qualification/design-in), cost advantages (integrated chemistry and manufacturing know-how), and intangible assets (formulation and application engineering competence).

  • Switching costs / design-in inertia: Engineered materials—especially where dimensional stability, thermal properties, chemical resistance, and processing behavior are critical—require testing, validation, and production process alignment. This favors established suppliers with proven performance history.
  • Cost and process advantages: Integrated acetyl-chemistry and downstream conversion capability support manufacturing efficiency and a tighter link between upstream feedstock economics and downstream product margins.
  • Technical and regulatory know-how: Specialty chemical products typically require robust quality systems and documentation, which raises the barrier for new entrants and supports long-term customer relationships.

Competitive benchmarking:

  • DuPont: Broad engineered materials and specialty chemicals footprint with strong capabilities in multiple polymer families; competes across segments but often with less emphasis on Celanese’s specific acetyl-chain and application niches.
  • LANXESS: Specialty chemicals and materials player with competitive positioning in technical compounds; competes on performance chemistries but does not mirror Celanese’s end-to-end acetyl-driven platform in the same way.
  • BASF: Diversified chemical platform spanning multiple value chains; competes with scale and breadth, while Celanese’s advantage is more concentrated in engineered materials where qualification and performance specificity drive stickiness.

Compared with these diversified peers, Celanese’s positioning emphasizes engineered materials specialization and application-driven differentiation—areas where switching costs and process know-how tend to matter more than pure commodity scale.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is likely supported by a mix of end-market expansion and substitution toward higher-performance materials:

  • Lightweighting and efficiency in transportation: Engineering polymers and performance materials benefit as vehicle designs prioritize fuel economy, thermal stability, and durability.
  • Durable materials for electronics and industrial equipment: Demand for materials that withstand heat, chemicals, and mechanical stress supports a structurally higher-value product mix.
  • Industrial automation and infrastructure modernization: Components and subassemblies in industrial equipment increasingly rely on engineered plastics and specialty chemical inputs.
  • Application expansion through technical partnership: Celanese’s design-in capability can create incremental share in applications where performance requirements are rising.

TAM expansion for specialty and engineered materials is typically less about category growth alone and more about share gains through qualification-driven adoption in new platforms and product redesign cycles.

⚠ Risk Factors to Monitor

  • Commodity and feedstock volatility: Changes in input chemical and energy costs can pressure margins if pricing does not fully track cost movement.
  • Industrial end-market cyclicality: Downturns in automotive and industrial production can reduce volumes and utilization rates.
  • Capacity additions and pricing discipline: New capacity in specialty chemicals can intensify competition and reduce pricing spreads.
  • Regulatory and environmental compliance: Specialty chemicals entail ongoing capital needs for emissions control, waste handling, worker safety, and regulatory reporting.
  • Technology substitution risk: Materials can be displaced if alternative polymers or composites outperform on cost, durability, or recyclability requirements for specific applications.

📊 Valuation & Market View

The market typically prices specialty chemicals and engineered materials businesses on a blend of earnings power and cash-flow durability, often using enterprise value to EBITDA as a primary lens and supplementing with free cash flow yield and cyclicality-adjusted valuation. Multiple compression and expansion generally track:

  • Margin and cost-spread stability (especially the relationship between input economics and downstream pricing).
  • Utilization and volume growth versus end-market expectations.
  • Capital efficiency (maintenance capex versus growth capex execution).
  • Quality of earnings, including the ability to sustain premium product mix through cycles.

Because outcomes depend on spreads and cycle management, investors typically emphasize normalized earnings capacity and balance-sheet resilience rather than short-term reporting volatility.

🔍 Investment Takeaway

Celanese presents a defensible specialty positioning anchored by switching costs from design-in dynamics and cost/process advantages from integrated chemistry. The long-term thesis rests on converting technical differentiation into durable customer qualification, sustaining a premium product mix through industrial cycles, and maintaining manufacturing efficiency despite input volatility. Key diligence focuses on margin durability, pricing discipline, execution of capital commitments, and the pace of customer adoption in higher-value applications.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for CE.

zacks.com2026-06-05

Celanese Streamlines Engineered Materials Network Across Asia

Celanese will close its Ulsan facility and shift Engineered Materials production to China and India to boost Asia's efficiency.

businesswire.com2026-06-04

Celanese to Optimize Engineered Materials Compounding Footprint in Asia Region

DALLAS--(BUSINESS WIRE)---- $CE--Celanese to Optimize Engineered Materials Compounding Footprint in Asia Region.

zacks.com2026-06-04

Celanese (CE) Down 10.7% Since Last Earnings Report: Can It Rebound?

Celanese (CE) reported earnings 30 days ago. What's next for the stock?

businesswire.com2026-05-19

Celanese Announces Engineered Materials Price Increase

DALLAS--(BUSINESS WIRE)---- $CE--Celanese Announces Engineered Materials Price Increase.

247wallst.com2026-05-12

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More

Pre-Market Stock Futures: The futures are trading lower on Tuesday, but another week and another set of new highs for the S&P 500 and the Nasdaq, as AI fever overshadowed Iran's peace counteroffer dismissal on Monday. The stock market opened lower on the rejection of President Trump's peace offering, but buyers once again circled the... Here Are Tuesday's Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe's, Matador Resources, Toast and More

businesswire.com2026-05-11

Celanese Announces Price Increases Across the Acetyl Chain

DALLAS--(BUSINESS WIRE)---- $CE--CELANESE ANNOUNCES PRICE INCREASES ACROSS THE ACETYL CHAIN.

marketbeat.com2026-05-09

Celanese Q1 Earnings Call Highlights

Celanese NYSE: CE executives said the company is prioritizing cash generation and operational flexibility as weak end-market demand continues, while supply chain disruptions are creating near-term opportunities in parts of its acetyls business.

seekingalpha.com2026-05-07

Celanese: Why I'm Buying The Q1 Post-Earnings Dip

Celanese remains a buy despite Q1 '26 earnings miss and macro-driven selloff, trading at under 10x earnings with a 9–10% free cash flow yield. CE's cost structure is improving through strategic asset closures, product mix upgrades, and targeted expansion in higher-margin specialty markets. Management guides for significant EPS recovery in Q2 and H2'26, assuming supply chain normalization post-Strait of Hormuz disruptions.

seekingalpha.com2026-05-06

Celanese Corporation (CE) Q1 2026 Earnings Call Transcript

Celanese Corporation (CE) Q1 2026 Earnings Call Transcript

zacks.com2026-05-06

Celanese Q1 Earnings Miss Estimates, Revenues Decline Y/Y

CE's Q1 earnings jump but miss estimates as sales dip on weak end markets. It expects a stronger Q2 with price gains, higher volumes and improved cash flow outlook.

zacks.com2026-05-05

Celanese (CE) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com2026-05-05

Celanese (CE) Lags Q1 Earnings Estimates

Celanese (CE) came out with quarterly earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.57 per share a year ago.

businesswire.com2026-05-05

Celanese Corporation Reports First Quarter Earnings

DALLAS--(BUSINESS WIRE)--Celanese Corporation Reports First Quarter Earnings.

businesswire.com2026-05-05

Celanese Outlines Strategic Nylon Uplift Initiatives for Global Engineered Materials Business

DALLAS--(BUSINESS WIRE)---- $CE--Celanese Outlines Strategic Nylon Uplift Initiatives for Global Engineered Materials Business.

benzinga.com2026-05-05

Top Wall Street Forecasters Revamp Celanese Expectations Ahead Of Q1 Earnings

Celanese Corporation (NYSE:CE) will release earnings for its first quarter after the closing bell on Tuesday, May 5.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"CE reported Q1 2026 revenue of $2.337B and net income of $115M (EPS $0.40). On a YoY basis (vs Q1 2025), revenue declined 2.1% (from $2.389B to $2.337B), while net income swung from a loss of $21M to a profit (+~648%). QoQ (vs Q4 2025), revenue rose 6.1% ($2.204B to $2.337B) and net income increased sharply from $19M to $115M (+~505%). Profitability improved: gross margin expanded to 20.0% (from 17.4% in Q4 2025; from 19.9% in Q1 2025), and net margin jumped to 4.9% (from 0.9% in Q4 2025; from -0.9% in Q1 2025). Operating income was $214M, reversing the prior year’s weak profitability. Cash flow quality strengthened in Q1 2026: operating cash flow was $76M and free cash flow was also $76M (no capex shown). The company remains balance-sheet levered, with total assets of $21.7B and equity of ~$4.5B. Net debt improved materially QoQ to $258M from $11.7B, indicating a significant balance-sheet de-risking, though absolute leverage appears still elevated given the historically large debt figures. Shareholder returns look strong on price momentum: CE is up 65.3% over the last year, which should materially lift total return. Dividend yield is negligible (~0.05%), and no buybacks/dividends are indicated in Q1 cash flow."

Revenue Growth

Neutral

QoQ revenue +6.1% (Q1'26 $2.337B vs Q4'25 $2.204B) but YoY revenue -2.1% (vs Q1'25 $2.389B). Trajectory improved sequentially but not on a yearly basis.

Profitability

Good

Net income rose to $115M vs $19M QoQ and vs -$21M YoY; net margin expanded to 4.9% from 0.9% QoQ and from -0.9% YoY. Gross margin also expanded vs Q4.

Cash Flow Quality

Neutral

Q1'26 operating cash flow/FCF both ~ $76M with modest scale. No dividends or buybacks were reported in Q1 cash flow; dividend yield is ~0.05% (not a meaningful source of returns).

Leverage & Balance Sheet

Neutral

Major-bank-style leverage metrics are not applicable, but balance sheet shows resilience: equity ~ $4.5B and total assets ~$21.7B. Net debt improved sharply QoQ to ~$258M from ~$11.7B, suggesting improved funding position.

Shareholder Returns

Good

Strong momentum: 1y price change +65.3% (well above +20%). Dividend is minimal, but the price return should dominate total shareholder return absent evidence of large buybacks.

Analyst Sentiment & Valuation

Fair

Price ($62.03) vs consensus target ($65.4) implies limited upside (~5%). Valuation multiples appear moderate to rich depending on cash-flow metrics, but no detailed forward estimates were provided here.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Celanese’s Q1 2026 call emphasizes a defensive earnings posture built around cash generation and operational flexibility rather than a fundamental demand recovery. The key underwriting for the back half is supply-chain unwind beginning late Q2, supporting the company’s referenced $3 EPS per-share back-half target. In the acetyl chain, management highlighted a nearly $200m Q1-to-Q2 profit lift weighted to the Western Hemisphere and concentrated in downstream vinyls (vinyl emulsions and redispersible powder) rather than acetic acid alone, with Frankfurt positioned as a swing/operating flex unit into 2H. In Engineered Materials, management acknowledged meaningful transition-driven absorption pressure (+$50m in 2H; ~$35m over the year) and a Q2 turnaround expense (~$15m), but paired it with a ~$30m Nylon 66 cost-savings plan (less than 1-year payback; ~1/3 in 2H) and Fortify actions to offset the drag. Risks center on prolonged low demand, prebuying dynamics, and shipping/feedstock disruptions affecting benzene equity income.

AI IconGrowth Catalysts

  • Vinyl emulsions and redispersible powder growth pockets driving downstream profitability in the acetyl chain (switching advantage in higher oil environment)
  • Engineered Materials (EM) focus on Nylon 66 compounding and specialty products to win in growth subsegments (medical, electronics, data centers, athletic wear, key industrial applications)
  • Customer switching opportunities in acetyls downstream offerings despite acetic acid price moderation regionally

Business Development

  • Securing additional Engineered Materials business not covered for the second half (customers renewing/expanding contract coverage as flex capacity is utilized)
  • Ongoing M&A pursuit: management expects to sign another deal in 2026 (could be smaller), but has not assumed cash proceeds due to sign-vs-close uncertainty

AI IconFinancial Highlights

  • Back-half 2026 EPS guidance referenced as $3 per share (management assumes supply chains unwind beginning late Q2, moderating volumes and margins into the second half)
  • Acetyl chain: Q1 to Q2 profit lift described as “a little less than $200 million”; lift weighted heavier to the Western Hemisphere and disproportionately tied to the vinyls downstream (VAM downstream into vinyl emulsions and redispersible powder), not acetic acid alone
  • Engineered Materials: management guided to an additional $50 million absorption hit in the second half from drawing nylon from the transition; management offset plan targets growth at year-end to more than offset absorption hits (~$35m over the year) plus turnaround expense (~$15m coming in Q2)
  • Price-cost timing in EM: pricing initially flows in Q2 but is expected to hit heavier in Q3, with “fully materialize in the P&L in the third quarter”; “next 6 weeks” are critical to achieving maximum price capture
  • Equity income benzene: assumes flattish 2026 versus 2025 earnings contribution due to a low 2025 base and assets impacted for ~6 weeks by shipping constraints and raw material feedstock disruption (1-quarter lag noted)

AI IconCapital Funding

    AI IconStrategy & Ops

    • Acetyl chain capacity/reliability posture: Clear Lake running at relatively high utilization; Frankfurt used as a swing unit and expected to operate into the second half under scenario planning, with turnarounds on two U.S. VAM units between now and end-of-year
    • Supply-chain scenario plan: management assumes supply chain unwind begins by end of Q2 and continues through Q3/Q4; described as a “coiled spring” where upside exists if demand/supply conditions improve
    • EM “Fortify” operations: cost reduction, reduction of complexity, and technology additions via the CAMIL platform; inventory permanently removed from the system as part of transition actions
    • Nylon 66 strategic initiatives in U.S. and Singapore: targeted incremental cost savings of ~$30 million; about 1/3 expected to hit in 2026 second half, and cash cost to achieve savings described as less than a 1-year payback (already included in free cash flow forecast for the year)

    AI IconMarket Outlook

    • Second-half acetyl/unwind assumption: supply chains start to unwind by end of Q2 (moderate volumes/margins through Q3 and Q4) and management remains ready to capture upside if conditions improve
    • Seasonality anchor for cadence: Chuck Kyrish indicated Q3 vs Q4 seasonality is about $25m–$30m in each business; expect similar pattern this year
    • Clear Lake: management stated margins are not near past peak demand/mid-cycle levels globally; opportunities are more downstream for acetic acid in vinyls chain than from fundamental acetic acid demand

    AI IconRisks & Headwinds

    • End-use demand described as “low” and constrained by supply chain disruption; management cited potential demand offset from high feedstock prices
    • Prebuying/front-loading risk: investors asked about demand disruption; management stated they are concerned and monitoring, and that front-loading may be seen in Engineered Materials (less so in acetyls per partial response)
    • Shipping constraints and raw material feedstock disruption impacting benzene plant operations for ~6 weeks (affecting equity income contribution with 1-quarter lag)
    • Regional pricing dispersion risk: acetyl pricing moderating in China from early-April levels and potential margin moderation in Q3; uncertainty remains on price balance globally

    Q&A: Analyst Interest

    • EPS and second-half build: Topic: Management’s $3 EPS per-share back-half framing hinges on scenario planning for supply-chain unwind starting by end of Q2, with moderation continuing through Q3/Q4; management described “coiled spring” upside if demand/supply improve and emphasized reliability over forecasting certainty.
    • EM nylon transition cost/absorption offsets: Topic: Management quantified an additional $50m EM absorption hit in 2H from drawing nylon from the transition, versus ~$35m absorption over the year, plus ~$15m turnaround expense in Q2, and argued Fortify actions and cost reductions/growth more than offset these headwinds by year-end.
    • Acetyl chain pricing cadence and regional effects: Topic: Management addressed acetyl pricing expectations, noting China pricing moderated and may stay where it is or moderate further, while Western Hemisphere pricing was near April’s watermark; they warned Q3 volume seasonality typically reduces volumes versus Q2 and factored margin/price moderation assumptions.

    Sentiment: MIXED

    Note: This summary was synthesized by AI from the CE Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

    📋 Official Regulatory 10-K / 10-Q SEC Filings

    Direct authenticated documentation links to audited SEC database reports for CE.

    SEC EDGAR Live Feed
    Loading financial data and tables...
    📁

    SEC Filings (CE)

    © 2026 Stock Market Info — Celanese Corporation (CE) Financial Profile